CDSCO UID IMP/IVD/2023/000392_cf242443fd5dc85836e30bbdac987375_e8fd048c5b3070e7f5dfe2593bcda4fb

NAISSA RSV IgM

M/s Vishat Diagnostic Pvt Ltd.·Device Class Class B·India CDSCO
Registration details
UID
IMP/IVD/2023/000392_cf242443fd5dc85836e30bbdac987375_e8fd048c5b3070e7f5dfe2593bcda4fb
Device class
Class B
Approving authority
CDSCO
Product information
"The test is intended for the qualitative detection of IgG/IgM antibodies against Respiratory syncytial Virus in human serum or plasma."
Other products from M/s Vishat Diagnostic Pvt Ltd.
Products from the same license holder (10 products)
Anti-dsDNA IgG
Class B
DHEA
Brand: E1
Class B
AMH
Class B
Anti-SS-B
Class B
Ferritin
Class B
NAISSA System liquid
Class B
Anti-SS-A
Class B
CCP IgG
Class B
PTH
Class B
SHBG
Brand: E1
Class B
About this record

NAISSA RSV IgM is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000392_cf242443fd5dc85836e30bbdac987375_e8fd048c5b3070e7f5dfe2593bcda4fb. The license holder is M/s Vishat Diagnostic Pvt Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.